Responding to Payor Policy Changes That Impact Patients with Postparalytic Facial Palsy: Chemodenervation with Botulinum Toxin.
APA
Miller MQ, Clark JM (2022). Responding to Payor Policy Changes That Impact Patients with Postparalytic Facial Palsy: Chemodenervation with Botulinum Toxin.. Facial plastic surgery & aesthetic medicine, 24(5), 335-336. https://doi.org/10.1089/fpsam.2021.0372
MLA
Miller MQ, et al.. "Responding to Payor Policy Changes That Impact Patients with Postparalytic Facial Palsy: Chemodenervation with Botulinum Toxin.." Facial plastic surgery & aesthetic medicine, vol. 24, no. 5, 2022, pp. 335-336.
PMID
35104419
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 1 |
MeSH Terms
Botulinum Toxins, Type A; Facial Paralysis; Humans; Nerve Block; Neuromuscular Agents; Policy
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
같은 제1저자의 인용 많은 논문 (1)
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.